Atlas Trials

A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

Clinical trial NCT03633708 · RECRUITING

Trial details

NCT number
NCT03633708
Sponsor
Amgen
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Secondary HyperparathyroidismChronic Kidney Disease
Start date
2019-04-29
Primary completion
2029-01-31
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.